# Multicenter Study of Iloprost Inhaled in Pulmonary Hypertension After Repair of Congenital Heart Diseases (CHD)

> **NCT01598441** · PHASE3 · COMPLETED · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 8 (actual)

## Conditions studied

- Pulmonary Hypertension

## Interventions

- **DRUG:** iloprost nebuliser solution
- **DRUG:** distilled water

## Key facts

- **NCT ID:** NCT01598441
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2016-11-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01598441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01598441, "Multicenter Study of Iloprost Inhaled in Pulmonary Hypertension After Repair of Congenital Heart Diseases (CHD)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01598441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*